Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Conor Medsystems |
---|---|
Information provided by: | Conor Medsystems |
ClinicalTrials.gov Identifier: | NCT00322543 |
Non-randomized, single arm, multi-center, clinical trial evaluating the Corio™ pimecrolimus-eluting stent with reduced anti-platelet therapy in patients with de novo lesions of the native coronary arteries.
Condition | Intervention | Phase |
---|---|---|
Coronary Disease |
Device: Corio™ Pimecrolimus-eluting stent |
Phase III |
Study Type: | Interventional |
Study Design: | Treatment, Non-Randomized, Open Label, Historical Control, Single Group Assignment, Safety/Efficacy Study |
Official Title: | Reduced Anti-Platelet Therapy With Pimecrolimus Drug Eluting Stent (RAPID) A Multi-Center Study of the Pimecrolimus-Eluting Cobalt Chromium Coronary Stent System (Corio™) in Patients With De Novo Lesions of the Native Coronary Arteries |
Enrollment: | 3 |
Study Start Date: | May 2006 |
Study Completion Date: | May 2008 |
Primary Completion Date: | November 2006 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
Drug eluting stent: Experimental
Corio™ Pimecrolimus-eluting stent
|
Device: Corio™ Pimecrolimus-eluting stent |
The registry is designed to evaluate 6-month in-stent late lumen loss in patients receiving the Corio™ drug-eluting stent.
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
General Inclusion Criteria
Exclusion Criteria:
General Exclusion Criteria
Brazil, SP | |
Institute Dante Pazzanese of Cardiology | |
Sao Paulo, SP, Brazil, 04012-180 |
Principal Investigator: | Alexandre Abizaid, M.D. | Institute Dante Pazzanese of Cardiology |
Responsible Party: | Institute Dante Pazzanese of Cardiology ( Alexandre Abizaid, MD ) |
Study ID Numbers: | RAPID (Genesis) Registry CP-02 |
Study First Received: | May 4, 2006 |
Last Updated: | October 16, 2008 |
ClinicalTrials.gov Identifier: | NCT00322543 |
Health Authority: | Brazil: National Committee of Ethics in Research |
Percutaneous coronary intervention (PCI) Drug eluting stent (DES) |
Arterial Occlusive Diseases Coronary Disease Heart Diseases Chromium Cobalt Myocardial Ischemia |
Vascular Diseases Pimecrolimus Arteriosclerosis Ischemia Coronary Artery Disease |
Anti-Inflammatory Agents Immunologic Factors Physiological Effects of Drugs Immunosuppressive Agents Pharmacologic Actions Analgesics, Non-Narcotic Sensory System Agents Therapeutic Uses |
Cardiovascular Diseases Anti-Inflammatory Agents, Non-Steroidal Analgesics Peripheral Nervous System Agents Antirheumatic Agents Central Nervous System Agents Dermatologic Agents |